1. N. Weiss, D. Galanaud, A. Carpentier, S. Tezenas de Montcel, L. Naccache, P. Coriat, and L. Puybasset. A combined clinical and MRI approach for outcome assessment of traumatic head injured comatose patients. J Neurol, 255(2):217-23, 2008. Note: Journal ArticleGermany. [WWW] Keyword(s): Adult, Analysis of Variance, Behavior/physiology, Brain/pathology, Brain Injuries/complications/*pathology, Coma/etiology/*pathology, Female, Functional Laterality/physiology, Glasgow Outcome Scale, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neurologic Examination, Prognosis, Prospective Studies, Treatment Outcome.



2. A. Idbaih, M. Kouwenhoven, J. Jeuken, A. Carpentier, T. Gorlia, M. Kros, P. French, O. Delattre, J. Y. Delattre, M. J. Van den Bent, and K. Hoang-Xuan. ``True and false''1p/19q codeletions in anaplastic oligodendrogial tumors. Neuropathology, pp sous-presse, 2007.



3. G. Kaloshi, A. Benouaich-Amiel, F. Diakite, S. Taillibert, J. Lejeune, F. Laigle-Donadey, M. A. Renard, W. Iraqi, A. Idbaih, S. Paris, L. Capelle, H. Duffau, P. Cornu, J. M. Simon, K. Mokhtari, M. Polivka, A. Omuro, A. Carpentier, M. Sanson, J. Y. Delattre, and K. Hoang-Xuan. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology, 68(21):1831-6, 2007. Note: Journal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adult, Aged, Antineoplastic Agents, Alkylating/administration & dosage, Brain Neoplasms/*drug therapy/*genetics/physiopathology, *Chromosome Deletion, Chromosomes, Human, Pair 1/genetics, Chromosomes, Human, Pair 19/genetics, DNA Mutational Analysis, Dacarbazine/administration & dosage/*analogs & derivatives, Drug Resistance, Neoplasm/*genetics, Female, Gene Expression Regulation, Neoplastic/drug effects/genetics, Genetic Screening, Genotype, Glioma/*drug therapy/*genetics/physiopathology, Humans, Loss of Heterozygosity/genetics, Male, Middle Aged, Neoplasm Recurrence, Local/drug therapy/genetics, Retrospective Studies, Survival Rate, Treatment Outcome.



4. A. Carpentier, D. Galanaud, L. Puybasset, J. C. Muller, T. Lescot, A. L. Boch, V. Riedl, P. Cornu, P. Coriat, D. Dormont, and R. van Effenterre. Early morphologic and spectroscopic magnetic resonance in severe traumatic brain injuries can detect ``invisible brain stem damage'' and predict ``vegetative states''. J Neurotrauma, 23(5):674-85, 2006. Note: Journal ArticleUnited States. [WWW] Keyword(s): Adult, Brain Injuries/*diagnosis/physiopathology, Brain Stem/*pathology, Evaluation Studies, Glasgow Coma Scale, Humans, *Magnetic Resonance Imaging, *Magnetic Resonance Spectroscopy, Persistent Vegetative State/*diagnosis, Principal Component Analysis, Prognosis, Prospective Studies, *Recovery of Function.



5. F. Laigle-Donadey, N. Martin-Duverneuil, J. Lejeune, E. Criniere, L. Capelle, H. Duffau, P. Cornu, P. Broet, M. Kujas, K. Mokhtari, A. Carpentier, M. Sanson, K. Hoang-Xuan, J. Thillet, and J. Y. Delattre. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology, 63(12):2360-2, 2004. Note: Comparative StudyJournal ArticleReviewUnited States. [WWW] Keyword(s): Adult, Aged, Brain Neoplasms/*genetics/pathology/*radiography, Cerebral Cortex/pathology/radiography, Chromosomes, Human, Pair 1/*genetics, Female, Humans, *Loss of Heterozygosity, Male, Microsatellite Repeats, Middle Aged, Oligodendroglioma/*genetics/pathology/*radiography, Retrospective Studies, Supratentorial Neoplasms/genetics/pathology/radiography.



6. M. Sanson, S. Cartalat-Carel, S. Taillibert, M. Napolitano, L. Djafari, J. Cougnard, H. Gervais, F. Laigle, A. Carpentier, K. Mokhtari, L. Taillandier, O. Chinot, H. Duffau, J. Honnorat, K. Hoang-Xuan, and J. Y. Delattre. Initial chemotherapy in gliomatosis cerebri. Neurology, 63(2):270-5, 2004. Note: ANOCEF groupClinical TrialComparative StudyControlled Clinical TrialJournal ArticleResearch Support, Non-U.S. Gov'tUnited States. [WWW] Keyword(s): Adolescent, Adult, Aged, Aged, 80 and over, Antineoplastic Agents, Alkylating/adverse effects/*therapeutic use, Antineoplastic Combined Chemotherapy Protocols/administration &, dosage/adverse effects/*therapeutic use, Astrocytoma/drug therapy/radiotherapy, Brain Neoplasms/*drug therapy/pathology/radiotherapy, Combined Modality Therapy, Cranial Irradiation, Dacarbazine/adverse effects/*analogs & derivatives/*therapeutic use, Disease Progression, Disease-Free Survival, Drug Administration Schedule, Female, Hematologic Diseases/chemically induced, Humans, Karnofsky Performance Status, Lomustine/administration & dosage/adverse effects, Magnetic Resonance Imaging, Male, Middle Aged, Neoplasms, Neuroepithelial/*drug therapy/pathology/radiotherapy, Oligodendroglioma/drug therapy/radiotherapy, Procarbazine/administration & dosage/adverse effects, Survival Analysis, Treatment Outcome, Vincristine/administration & dosage/adverse effects.



7. B. Benyahia, Z. Amoura, A. Rousseau, C. Le Clanche, A. Carpentier, J. C. Piette, and J. Y. Delattre. Paraneoplastic antineuronal antibodies in patients with systemic autoimmune diseases. J Neurooncol, 62(3):349-51, 2003. Note: Journal ArticleNetherlands. [WWW] Keyword(s): Antigens, Neoplasm/immunology, Autoantibodies/*blood, Autoantigens, DNA-Binding Proteins/immunology, Hu Paraneoplastic Encephalomyelitis Antigens, Humans, Lupus Erythematosus, Systemic/*immunology, Neoplasm Proteins/immunology, Nerve Tissue Proteins/*immunology, Neurons/*immunology, Paraneoplastic Syndromes/*immunology, RNA-Binding Proteins/*immunology, Recombinant Proteins/*immunology, Sjogren's Syndrome/*immunology.



8. S. Oudard, A. Carpentier, E. Banu, F. Fauchon, D. Celerier, M. F. Poupon, B. Dutrillaux, J. M. Andrieu, and J. Y. Delattre. Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme. J Neurooncol, 63(1):81-6, 2003. Note: Clinical TrialClinical Trial, Phase IIJournal ArticleMulticenter StudyResearch Support, Non-U.S. Gov'tNetherlands. [WWW] Keyword(s): Adult, Antineoplastic Combined Chemotherapy Protocols/adverse, effects/*therapeutic use, Brain Neoplasms/*drug therapy/pathology, Diazepam/administration & dosage, Female, Glioblastoma/*drug therapy/pathology, Humans, Indazoles/administration & dosage, Male, Middle Aged, Neoplasm Recurrence, Local/*drug therapy/pathology, Prognosis, Survival Rate.

This material is presented to ensure timely dissemination of scholarly and technical work. Copyright and all rights therein are retained by authors or by other copyright holders. All person copying this information are expected to adhere to the terms and constraints invoked by each author's copyright. In most cases, these works may not be reposted without the explicit permission of the copyright holder.

Les documents contenus dans ces répertoires sont rendus disponibles par les auteurs qui y ont contribué en vue d'assurer la diffusion à temps de travaux savants et techniques sur une base non-commerciale. Les droits de copie et autres droits sont gardés par les auteurs et par les détenteurs du copyright, en dépit du fait qu'ils présentent ici leurs travaux sous forme électronique. Les personnes copiant ces informations doivent adhérer aux termes et contraintes couverts par le copyright de chaque auteur. Ces travaux ne peuvent pas être rendus disponibles ailleurs sans la permission explicite du détenteur du copyright.

This document was translated from BibT_EX by bibtex2html